AI-driven computational biology platform decoding tumor microenvironment cell–cell communications to generate a patient-specific metric that identifies actionable molecular interactions and predicts response to immune checkpoint inhibitors, monoclonal antibodies, and small-molecule immune modulators. Supports precision medicine and optimized clinical trial design by matching immunotherapeutic drugs or combinations to the right patients and indications.